Search…

Lates News

23/09/2025

According to Every AI Newsflash, Huaxin Securities released a research report on September 23, giving Weis Medical (688580.SH) a buy rating. The reasons for the rating mainly include: 1) The company's expense ratio continued to improve in Q2 2025, leading to a substantial increase in profits; 2) The cornerstone business is stable, with high-speed growth in laser radiofrequency and electrophysiology products. (Daily Economic News)

Latest

1 m ago

China Association of Automobile Manufacturers: The top ten SUV production companies in terms of sales from January to August 2025 collectively sold 6.488 million vehicles.

1 m ago

The Hong Kong dollar interbank interest rates have risen again, with the one month interbank rate rising for the fourth day in a row to 3.91%, reaching a four-month high.

1 m ago

The Royal Bank of Canada has upgraded its rating on Volkswagen Group from "in line with market performance" to "outperform market performance"; and raised its target price from 117 euros to 130 euros.

1 m ago

The Royal Bank of Canada (RBC) has upgraded Volkswagen Group's rating from "in line with the market" to "outperforming the market"; and raised the target price from 117 euros to 130 euros.

3 m ago

Hong Kong-listed stock anomaly | Kangfang Biology (09926.HK) up nearly 5% Evosi HARMONi-6 research results selected for ESMO LBA 2025

See all latest